RemeGen Co., Ltd. 榮昌生物製藥（煙台）股份有限公司
Pay for financial year ended 2021-12-31
| Name | Last position |
Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|---|
CNY '000 |
||||||||
Supervisors |
||||||||
| 1 | Li, Yupeng (1983) 李宇鵬 | Supervisor | ||||||
| 2 | Li, Zhuanglin 李壯林 | Supervisor | 1,177 | 210 | 36 | 526 | 1,949 | |
| 3 | Ren, Guangke 任廣科 | Sup Ch | 688 | 110 | 36 | 1,297 | 2,131 | |
| Total | 0 | 1,865 | 320 | 72 | 1,823 | 4,080 | ||
Directors |
||||||||
| 4 | Babiuk, Lorne Alan | INED | 125 | 125 | ||||
| 5 | Fang, Jianmin (1962) 房健民 | CEO, Co-Fdr | 3,714 | 3,950 | 36 | 7,700 | ||
| 6 | Hao, Xianjing 郝先經 | INED | 300 | 300 | ||||
| 7 | He, Ruyi 何如意 | ED | 3,880 | 300 | 36 | 6,271 | 10,487 | |
| 8 | Lin, Jian (1955) 林健 | ED | 480 | 403 | 883 | |||
| 9 | Ma, Lan (1957) 馬蘭 | INED | 175 | 175 | ||||
| 10 | Su, Xiaodi 蘇曉迪 | NED | ||||||
| 11 | Wang, Liqiang (1970) 王荔強 | NED | ||||||
| 12 | Wang, Weidong (1959) 王威東 | Ch | 840 | 660 | 1,500 | |||
| 13 | Yu, Shanshan (SFC:AZU832) 于珊珊 | INED | 300 | 300 | ||||
| Total | 900 | 8,914 | 5,313 | 72 | 6,271 | 21,470 | ||
| Grand total | 900 | 10,779 | 5,633 | 144 | 8,094 | 25,550 | ||
Main board pay history
Click on the year-end to see the pay details.
CNY'000
| Year-end | Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | 2,317 | 14,409 | 3,709 | 41 | 35,376 | 55,852 | Report |
| 2022-12-31 | 2,293 | 14,414 | 3,878 | 77 | 36,763 | 57,425 | Report |
| 2021-12-31 | 900 | 8,914 | 5,313 | 72 | 6,271 | 21,470 | Report |
| 2020-12-31 | 576 | 10,114 | 2,983 | 6 | 4,648 | 18,327 | Report |
| Total | 6,086 | 47,851 | 15,883 | 196 | 83,058 | 153,074 |
Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy